Article Versions Notes

Eilsberger F, Ebrahimifard A, Spiegel FT, Yousefi BH, Bagheri S, Bowl W, Wang Q, Pfestroff A, Müller L, Luster M, et al. Therapeutic Consequences of ⁶⁸Ga-PSMA-11-PET/CT in Prostate Cancer in Correlation to the Gleason Score, PSA Value, and D’Amico-Defined Risk Groups. Cancers. 2025; 17(12):1944. https://doi.org/10.3390/cancers17121944

Eilsberger, Friederike, Ali Ebrahimifard, Florian Torsten Spiegel, Behrooz Hooshyar Yousefi, Shamim Bagheri, Wadim Bowl, Qi Wang, Andreas Pfestroff, Laura Müller, Markus Luster, and et al. 2025. "Therapeutic Consequences of ⁶⁸Ga-PSMA-11-PET/CT in Prostate Cancer in Correlation to the Gleason Score, PSA Value, and D’Amico-Defined Risk Groups" Cancers 17, no. 12: 1944. https://doi.org/10.3390/cancers17121944

Eilsberger, F., Ebrahimifard, A., Spiegel, F. T., Yousefi, B. H., Bagheri, S., Bowl, W., Wang, Q., Pfestroff, A., Müller, L., Luster, M., Di Fazio, P., & Librizzi, D. (2025). Therapeutic Consequences of ⁶⁸Ga-PSMA-11-PET/CT in Prostate Cancer in Correlation to the Gleason Score, PSA Value, and D’Amico-Defined Risk Groups. Cancers, 17(12), 1944. https://doi.org/10.3390/cancers17121944